Active substance:
Canarypox virus expressing Influenza A virus, A/eq/Richmond/1/07 (H3N8), Live (vCP3011), Canarypox virus expressing Influenza A virus, A/equi-2/Ohio/03 (H3N8), Live (vCP2242)
Drug form:
Injekční suspenze
Registration date:
13. 02. 2006
Registration number:
EU/2/03/037
Verdict holder:
Boehringer Ingelheim Vetmedica, GmbH
Binger Strasse 173
Ingelheim am Rhein 55216
ATC vet. code:
QI05AD02 - Equine influenza virus vaccine
Pharmacotherapeutic group:
Live viral vaccines
Narcotic and psychotropic substances:
No
Withdrawal period:
Koně
Maso: 0 d.
Mléko: 0 h.